HUP0004223A2 - 4-Oxo-butánsav-származékok és ezeket hatóanyagként tartalmazó gyógyászati készítmények - Google Patents
4-Oxo-butánsav-származékok és ezeket hatóanyagként tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP0004223A2 HUP0004223A2 HU0004223A HUP0004223A HUP0004223A2 HU P0004223 A2 HUP0004223 A2 HU P0004223A2 HU 0004223 A HU0004223 A HU 0004223A HU P0004223 A HUP0004223 A HU P0004223A HU P0004223 A2 HUP0004223 A2 HU P0004223A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- carbon atoms
- general formula
- substituents
- pyrimidyl
- Prior art date
Links
- GFXJNGOOVZVTSF-UHFFFAOYSA-N 4-oxobut-2-ynoic acid Chemical class OC(=O)C#CC=O GFXJNGOOVZVTSF-UHFFFAOYSA-N 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- -1 cyano, hydroxyl Chemical group 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002541 furyl group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 2
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 2
- 125000001544 thienyl group Chemical group 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000005936 piperidyl group Chemical group 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 abstract 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A találmány hatóanyagként valamely (I) általános képletű vegyületet,ennek szolvátját vagy valamely gyógyászatilag elfogadható bázissalalkotott sóját tartalmazó, elsősorban nem inzulinfüggő diabéteszkezelésére alkalmazható gyógyászati készítményekre vonatkozik. Az (I)általános képletben A és B egymástól függetlenül - 6-14 szénatomosmono-, bi- vagy triciklusos arilcsoport; - heteroaromás csoport, melypiridil-, pirimidil-, pirrolil-, furil- vagy tienilcsoport lehet; - 1-4 szénatomos alkilcsoport; - 5-8 szénatomos cikloalkilcsoport; -telített heterociklusos csoport, mely tetrahidrofuril-,tetrahidropiranil-, piperidil- vagy pirrolidinilcsoport lehet; és A ésB 1-3 szubsztituenst tartalmazhat a következők közül: alkil-, alkoxi-,arilcsoport; heteroarilcsoport, mely piridil-, pirimidil-, pirrolil-,furil- vagy tienilcsoport lehet; aril-alkil-csoport; aril-alkil-aril-csoport; halogénatom; trifluor-metil-, trifluor-metoxi-, ciano-,hidroxil-, nitro-, amino-, karboxilcsoport; alkoxi-karbonil-csoport;karbamoilcsoport; alkil-szulfonil-amino-csoport; szulfamoilcsoportvagy alkil-karbonil-amino-csoport; vagy a szubsztituensek közül kettőmetilén-dioxi-csoportot alkot. A találmány az új (I) általános képletűvegyületekre is vonatkozik, ahol a helyettesítők jelentése - bizonyosmegszorításokkal - a fenti. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9610254A FR2752422B1 (fr) | 1996-08-16 | 1996-08-16 | Composition pharmaceutique contenant des acides 4-oxo-butanoiques |
PCT/EP1997/004252 WO1998007681A1 (fr) | 1996-08-16 | 1997-08-05 | Compositions pharmaceutiques contenant des acides 4-oxo-butanoiques |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0004223A2 true HUP0004223A2 (hu) | 2001-04-28 |
HUP0004223A3 HUP0004223A3 (en) | 2001-12-28 |
Family
ID=9495089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0004223A HUP0004223A3 (en) | 1996-08-16 | 1997-08-05 | 4-oxo-butynic acids and pharmaceutical composition containing them as active agent |
Country Status (30)
Country | Link |
---|---|
US (1) | US6143787A (hu) |
EP (1) | EP0925273B1 (hu) |
JP (1) | JP3105545B2 (hu) |
KR (1) | KR100488430B1 (hu) |
CN (1) | CN1082370C (hu) |
AR (1) | AR009251A1 (hu) |
AT (1) | ATE208364T1 (hu) |
AU (1) | AU725440B2 (hu) |
BR (1) | BR9711315A (hu) |
CA (1) | CA2263348C (hu) |
CY (1) | CY2298B1 (hu) |
CZ (1) | CZ294165B6 (hu) |
DE (1) | DE69708130T2 (hu) |
DK (1) | DK0925273T3 (hu) |
ES (1) | ES2166098T3 (hu) |
FR (1) | FR2752422B1 (hu) |
HK (1) | HK1021728A1 (hu) |
HU (1) | HUP0004223A3 (hu) |
ID (1) | ID17875A (hu) |
NO (1) | NO312290B1 (hu) |
PL (1) | PL187371B1 (hu) |
PT (1) | PT925273E (hu) |
RU (1) | RU2175966C2 (hu) |
SI (1) | SI0925273T1 (hu) |
SK (1) | SK283055B6 (hu) |
TR (1) | TR199900329T2 (hu) |
TW (1) | TW438764B (hu) |
UA (1) | UA57031C2 (hu) |
WO (1) | WO1998007681A1 (hu) |
ZA (1) | ZA977327B (hu) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04318852A (ja) * | 1991-04-18 | 1992-11-10 | Fujitsu Ltd | レジスト・パターン形成方法 |
WO2002100341A2 (en) | 2001-06-12 | 2002-12-19 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
FR2832633B1 (fr) * | 2001-11-28 | 2004-09-24 | Lipha | Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete |
FR2832925B1 (fr) * | 2001-12-03 | 2006-07-14 | Lipha | Utilisation de derives de l'acide 4-oxobutanoique dans le traitement de l'inflammation |
FR2834214B1 (fr) * | 2001-12-28 | 2004-09-24 | Lipha | Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete |
FR2834640B1 (fr) * | 2002-01-11 | 2004-09-24 | Lipha | Composition pharmaceutique comprenant une glitazone et un acide 4-oxobutanoique et son utilisation pour traiter le diabete |
EP1556085A4 (en) * | 2002-11-01 | 2012-08-22 | Wellstat Therapeutics Corp | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS |
AU2003275939A1 (en) * | 2002-11-08 | 2004-06-07 | Novo Nordisk A/S | Safe chemical uncouplers for the treatment of obesity |
FR2849598B1 (fr) * | 2003-01-07 | 2006-09-22 | Merck Sante Sas | Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete, par augmentation du nombre de cellules des ilots de langerhans |
FR2849599B1 (fr) * | 2003-01-07 | 2006-12-29 | Merck Sante Sas | Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete |
CN101912380A (zh) * | 2003-04-15 | 2010-12-15 | 维尔斯达医疗公司 | 用于治疗代谢紊乱的化合物 |
ES2368692T3 (es) | 2007-12-03 | 2011-11-21 | Merck Patent Gmbh | Utilización de derivados del ácido 4-oxobutanoico en el tratamiento de patologías asociadas con trastornos inmunológicos. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK523288A (da) * | 1987-10-06 | 1989-04-07 | Hoffmann La Roche | Aminosyrederivater |
US5250517A (en) * | 1987-10-06 | 1993-10-05 | Hoffmann-La Roche Inc. | Renin inhibiting compounds |
US5055466A (en) * | 1987-11-23 | 1991-10-08 | E. R. Squibb & Sons, Inc. | N-morpholino derivatives and their use as anti-hypertensive agents |
CA1329680C (en) * | 1987-11-23 | 1994-05-17 | Harold Norris Weller, Iii | N-heterocyclic alcohol derivatives |
-
1996
- 1996-08-16 FR FR9610254A patent/FR2752422B1/fr not_active Expired - Fee Related
-
1997
- 1997-05-08 UA UA99031301A patent/UA57031C2/uk unknown
- 1997-08-05 DK DK97936682T patent/DK0925273T3/da active
- 1997-08-05 US US09/230,849 patent/US6143787A/en not_active Expired - Fee Related
- 1997-08-05 CZ CZ1999498A patent/CZ294165B6/cs not_active IP Right Cessation
- 1997-08-05 BR BR9711315A patent/BR9711315A/pt not_active IP Right Cessation
- 1997-08-05 ES ES97936682T patent/ES2166098T3/es not_active Expired - Lifetime
- 1997-08-05 JP JP10510330A patent/JP3105545B2/ja not_active Expired - Fee Related
- 1997-08-05 CN CN97197180A patent/CN1082370C/zh not_active Expired - Fee Related
- 1997-08-05 AU AU39422/97A patent/AU725440B2/en not_active Ceased
- 1997-08-05 KR KR10-1999-7001122A patent/KR100488430B1/ko not_active IP Right Cessation
- 1997-08-05 DE DE69708130T patent/DE69708130T2/de not_active Expired - Lifetime
- 1997-08-05 TR TR1999/00329T patent/TR199900329T2/xx unknown
- 1997-08-05 SK SK180-99A patent/SK283055B6/sk not_active IP Right Cessation
- 1997-08-05 WO PCT/EP1997/004252 patent/WO1998007681A1/fr active IP Right Grant
- 1997-08-05 SI SI9730237T patent/SI0925273T1/xx unknown
- 1997-08-05 EP EP97936682A patent/EP0925273B1/fr not_active Expired - Lifetime
- 1997-08-05 HU HU0004223A patent/HUP0004223A3/hu unknown
- 1997-08-05 AT AT97936682T patent/ATE208364T1/de not_active IP Right Cessation
- 1997-08-05 CA CA002263348A patent/CA2263348C/en not_active Expired - Fee Related
- 1997-08-05 PT PT97936682T patent/PT925273E/pt unknown
- 1997-08-05 RU RU99105208/04A patent/RU2175966C2/ru not_active IP Right Cessation
- 1997-08-14 ID IDP972848A patent/ID17875A/id unknown
- 1997-08-14 ZA ZA9707327A patent/ZA977327B/xx unknown
- 1997-08-15 AR ARP970103720A patent/AR009251A1/es active IP Right Grant
- 1997-10-23 TW TW086115700A patent/TW438764B/zh active
-
1999
- 1999-02-12 PL PL97331645A patent/PL187371B1/pl not_active IP Right Cessation
- 1999-02-15 NO NO19990707A patent/NO312290B1/no not_active IP Right Cessation
-
2000
- 2000-01-31 HK HK00100582A patent/HK1021728A1/xx not_active IP Right Cessation
-
2002
- 2002-09-24 CY CY0200057A patent/CY2298B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA66827C2 (uk) | Дициклічні гетероароматичні сполуки як інгібітори білкової тирозинкінази | |
HUP0004223A2 (hu) | 4-Oxo-butánsav-származékok és ezeket hatóanyagként tartalmazó gyógyászati készítmények | |
RU2001107897A (ru) | Фармацевтическая композиция для лечения гепатита | |
KR890006540A (ko) | I-데속시노지리마이신 및 i- 데속시만노노지리마이신의 n-치환유도체, 이들의 제조방법 및 의약제로서의 용도 | |
WO2005011656A3 (en) | Pyridyl derivatives and their use as therapeutic agents | |
CA2443918A1 (en) | Visual function disorder improving agents containing rho kinase inhibitors | |
HUP0003250A1 (hu) | Káliumcsatorna gátló hatású indánszármazékok és az ezeket tartalmazó gyógyszerkészítmények | |
BG103195A (en) | Substituted indazole derivatives and their application as inhibitors of phosphodiesterase (pde) type iv and of the production of a tumournecrotic factor (tnf) | |
AU8179094A (en) | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals | |
AU9453098A (en) | Imidazole derivatives and their use as farnesyl protein transferase inhibit ors | |
RU2003134544A (ru) | Амиды антраниловой кислоты, способы их получения, их применение в качестве антиаритмических средств, а также содержащие их фармацевтические композиции | |
RU2002111561A (ru) | 2'-замещенные 1,1'-бифенил-2-карбонамиды, способы их получения, их применение в качестве лекарственного средства, а также содержащие их фармацевтические композиции | |
AU3588693A (en) | N-benzyloxamic acid, oxamate, and oxamide derivatives and their use as TNF and PDE IV inhibitors | |
BR0315580A (pt) | Derivados de metileno uréia | |
WO1995009619A3 (en) | Substituted urea and isothiourea derivatives as no synthase inhibitors | |
HUP0001110A2 (hu) | 3-Piridil-enantiomerek és analgetikumkénti alkalmazásuk | |
WO2006016067A3 (fr) | Derives de pyrido-pyrimidine, leur preparation, leur application dans le traitement du cancer | |
GEP20053626B (en) | Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof | |
SE0300908D0 (sv) | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | |
WO2003051274A3 (en) | Benzodiazepine derivatives, preparation thereof and use thereof | |
HUP0100276A2 (hu) | Szubsztituált krománszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
KR940703655A (ko) | 약제학적 조성물과 그 제조방법 | |
FI874865A (fi) | Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi | |
IE901683L (en) | Compounds | |
RU94039545A (ru) | Новые производные аденозина, способы их получения, фармацевтические композиции на их основе, способы получения фармацевтических композиций и их применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |